JNM Podcast

Nuclear medicine’s greatest promise is improving patient’s lives, both in quality and longevity, and no one knows that more than patients who have had first-hand experience with nuclear medicine. In fact, it’s often the patients themselves that are our field's greatest advocates. From becoming ambassadors for nuclear medicine to championing FDA approvals of new radiopharmaceuticals to lobbying lawmakers for change, our patients are our most powerful asset. On this episode of the JNM Podcast, host Ken Herrmann and physician Lisa Bodei are joined by two patients: Brittany McKelvey, chair of SNMMI’s Patient Advisory Advocate Board, and Josh Mailman, a patient with extensive leadership experience in the neuroendocrine tumors space. Together, they discuss the role of patient advocacy - whether that’s in the clinic, the halls of government, or in their everyday lives. Now streaming wherever you listen to podcasts. This episode is sponsored by SOFIE Biosciences.

Today the JNM Podcast is tackling an in-depth and technical topic: FDA approval pathways for new versions of current radiopharmaceuticals. Often called equivalents, the hope is that these “new” drugs can be expedited to the market by taking the same approval pathway of older, but similar versions. Joining host Ken Herrmann to help navigate these regulatory frameworks are two experts: Tom Hope, MD, and Aman Chauhan, MD. Tune in wherever you stream podcasts! 

The NCI Cancer Therapy Evaluation Program (CTEP) Investigational Drug Branch (IDB) offers a no-cost, 4 to 8-week externship at the NCI Shady Grove Campus in Rockville, MD. (https://dctd.cancer.gov/programs/ctep)

Key Details

• Target Audience: Medical/radiation oncology fellows or junior faculty (within 7 years of training completion).
• Focus: Participants shadow IDB Medical Officers, observe trial development, and learn to write Letters of Intent (LOIs).
• Logistics: Participants are responsible for their own room, board, and travel expenses.
• Application: Space is limited to 4 participants per month, with inquiries handled through the ETCTN CRDL Program. 

Thank you to Curium for sponsoring this episode. https://www.curiumpharma.com/

When it comes to your health, it helps to have the full picture. That’s why total-body PET is such a critical development in medical science: in just one scan, total-body PET can capture every organ and its function from head to toe. This modality is especially helpful for patients with diseases like melanoma or rheumatoid arthritis, as well as various immunology studies that involve analyzing bone marrow. In this episode of the JNM Podcast, host Ken Herrmann is joined by Simon Cherry, Michael Hofman, and Stefano Fanti to discuss the origins, evolution, and applications of total-body PET. Tune in on YouTube or wherever you stream podcasts.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California, with Johannes Czernin, MD, and Phillip J. Koo, MD.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.

Live from the 2026 SNMMI Annual Meeting in Los Angeles, California.